Founded in 2005, Triomed AB is a Swedish medical engineering company that has developed a new method for continuous dialysis treatment for patients with renal failure. The company's modular dialysis system addresses the key reasons patients leave peritoneal dialysis and adapts to treat the patient in the different stages of their disease progression. Triomed AB aims to improve the lives of end-stage renal disease patients by providing them with improved treatment at reduced costs. Patient safety is fundamental and the company follows laws and regulations applicable to the field of industry to ensure compliance with MDD 93/42/EEC and applicable ISO standards. Triomed AB values its external partners and works in close cooperation with them to achieve top production performance and distribution of its specifications.